GenScript Life Science Group is a part of GenScript Biotech Corporation. Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop ground breaking treatments and products. As a cornerstone of the global life science ecosystem, GenScript actively collaborates with a diverse network of partners—from academic institutions to industry leaders—to co-create cutting-edge solutions that redefine service excellence. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a well-recognized biotechnology company, GenScript has become a trusted global partner with a team of approximately 6,165 employees, supporting over 200,000 customers across 100+ countries and regions, including the world’s Top 20 pharma companies.
解锁市场时间线与信号动态
新增 合作伙伴 活动 — 刚出现 1 个新信号。
该公司进入各个市场的顺序 — 从最早到最新
20 active postings
Biotechnologist (Gene)
注册以查看完整信号动态
GenScript 的国际扩张与竞争对手的对比情况
GenScript你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 GenScript你 | 7 | 2 | -54% | 57 | 38 |
QA Engineer (Onsite)
查看职位Singapore, Singapore · 昨天
Biotechnologist (Gene-Trouble Shooting & Order Management)
查看职位Singapore, Singapore · 前天
Lean Specialist
查看职位Piscataway, NJ · 5天前
The 𝗧𝘂𝗿𝗯𝗼𝗖𝗛𝗢™ 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗞𝗶𝘁 is designed to accelerate antibody and recombinant protein production with strong, consistent performance across formats.Built on next-generation CHO expression technology, TurboCHO™ helps streamline early-stage discovery workflows while maintaining high yield and reliability.Key performance highlights:⏱️ Compared to existing products on the market, the kit achieves 𝗵𝗶𝗴𝗵𝗲𝗿 𝘁𝗶𝘁𝗲𝗿𝘀 𝗶𝗻 𝗷𝘂𝘀𝘁 𝗵𝗮𝗹𝗳 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲, ...
已结束
The 𝗧𝘂𝗿𝗯𝗼𝗖𝗛𝗢™ 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗞𝗶𝘁 is designed to accelerate antibody and recombinant protein production with strong, consistent performance across formats.Built on next-generation CHO expression technology, TurboCHO™ helps streamline early-stage discovery workflows while maintaining high yield and reliability.Key performance highlights:⏱️ Compared to existing products on the market, the kit achieves 𝗵𝗶𝗴𝗵𝗲𝗿 𝘁𝗶𝘁𝗲𝗿𝘀 𝗶𝗻 𝗷𝘂𝘀𝘁 𝗵𝗮𝗹𝗳 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲, ...
已结束Olvídate de inconsistencias entre lotes: expresa proteínas de forma automatizada.
已结束金斯瑞生物科技2025年上半年收入增长81.9%至5.188亿美元，经调整净利润增长509.6%至1.78亿美元，得益于全球扩张和各业务领域的创新。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 GenScript 的业务、市场和增长信号的快速解答。
